default author photo

Viktoria Anselm

SIGNATOPE GmbH

SCHOLARLY PAPERS

1

DOWNLOADS

160

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Antiviral and Immunomodulatory Effect of Zapnometinib in Animal Models and Hospitalized COVID-19 Patients

Number of pages: 59 Posted: 14 Dec 2023
University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, Atriva Therapeutics GmbH, Atriva Therapeutics GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, Utrecht University, Utrecht University - Division of Pathology, Cerba Research Company, Cerba Research Company, University of Münster, University of Münster and University of Tübingen
Downloads 160 (467,092)

Abstract:

Loading...

zapnometinib, MEK inhibitor, host targeting agent, COVID-19, drug development, broad-spectrum antiviral